Clustering of thrombotic factors with insulin resistance in South Asian patients with ischaemic stroke

Thrombosis and Haemostasis

Volumn 88, Issue 6, 2002, Pages 950-953

  Kain, Kirti ^a   Catto, Andrew J ^a   Grant, Peter J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Ethnic; Haemostasis; Insulin; South Asian; Stroke

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7 ANTIGEN; FIBRINOGEN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 1 ANTIGEN; THROMBOCYTE FACTOR; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ANAMNESIS; ANTHROPOMETRY; ARTICLE; ASIAN; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HEMOSTASIS; HIP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC PARAMETERS; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE; SOUTH ASIA; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; VASCULAR DISEASE;

EID: 0036908136     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613339     Document Type: Article

References (16)

1. Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Stroke 1998; 29 (9): 1860-6.
2. Lakka HM, Lakka TA, Tuomilehto J, Sivenius J, Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 2000; 160 (8): 1160-8.
3. Juhan-Vague I, Alessi MC, Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med 1996; 28 (4): 371-80.
4. Juhan-Vague I, Thompson SG, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb 1993; 13 (12): 1865-73.
5. Wild S, McKeigue PM. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ 1997; 314 (7082) 705-10.
6. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337 (8738): 382-6.
7. Kain K, Catto AJ, Grant PJ. Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects. Atherosclerosis 2001; 156 (2): 457-61.
8. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356 (9226): 279-84.
9. Kain K, Catto AJ, Young J, Bamford J, Bavington J, Grant PJ. Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke. Atherosclerosis 2002; 63 (2): 371-6.
10. Bamford J, Sandercock PA, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337 (8756): 1521-6.
11. Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996; 27 (1): 37-43.
12. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 1999; 20 (2): 538-44.
13. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311 (8): 501-5.
14. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343 (8903): 940-3.
15. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997; 78 (6): 555-63.
16. Kain K, Catto AJ, Young J, Bamford J, Bavington J, Grant PJ. Insulin resistance and elevated levels of tissue plasminogen activator in first-degree relatives of South Asian patients with ischemic cerebrovascular disease. Stroke 2001; 32 (5): 1069-73.